comprehensive -WSS

comprehensive

author：explore 2025-09-30 17:27:44 - browse：62846

Adam's take main illustration — Molly Ferguson/STAT

I am one week away from the launch of my weekly email newsletter! It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

Do you have a biotech-related question you want me to answer in the newsletter? Send me an email at [email protected].

This week: A preview of Intra-Cellular Therapies’ Phase 3 study in major depressive disorder, and a couple of liver-disease physician perspectives on Rezdiffra, the newly approved treatment for MASH from Madrigal Pharmaceuticals.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Apple Vision Pro: A first look at health apps on the new VR headset

hotspot

focus

WSS

General Catalyst, Summa Health deal will turn on physician buy

Covid misinformation case heads to Supreme Court

Some dementia cases could be undiagnosed liver disease

The real point of Kenneth Smith’s execution by nitrogen gas

New Ultima Genomics DNA sequencer can read genome for $100

Vertigo drug brings hope for rare neuron disorder, Niemann

knowledge

comprehensive

entertainment

In Memoriam: Notable people who died in 2023

Some dementia cases could be undiagnosed liver disease

Guidelines to prevent youth baseball injuries need more muscle

Even great ERs can’t make up for American health disparities

Jerome Adams on the need for new antivirals for Covid

Do digital therapeutics have a future in medicine?

Sports medicine is finally prioritizing gender equality

Commercial surrogacy can be ethical, despite pope’s claims

Medicare details structure of new drug price negotiation program

Commercial surrogacy can be ethical, despite pope’s claims

entertainment

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

SAMSHA loosens regulations on methadone treatment centers

New Ultima Genomics DNA sequencer can read genome for $100

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

What we need to know about Arena Bioworks

hotspot

focus

hotspot

hotspot